Our research on pancreatic cancer

Although survival rates for several types of cancer have improved over the years, pancreatic cancer is particularly hard to treat, partly because it’s often diagnosed late. That’s why research into pancreatic cancer is one of our key priorities.

Help us beat pancreatic cancer sooner

Our life-saving work relies on the money you give us.

Donate now and together we can save more lives.

Donate now

Pancreatic cancer and my family

Richie's mother sadly passed away after being diagnosed with pancreatic cancer. In 2009 Richie had the same diagnosis, but after surgery and chemotherapy he is now in remission. 

Promising research into pancreatic cancer

Dr Jennifer Morton’s research has pinpointed a genetic fault in a type of pancreatic cancer and matched it up with a drug,  rapamycin. Early results indicate the drug can shrink tumours in mice.

Extending life

Prof Jeff Evans will lead a trial in the UK to find out if Abraxane can improve life expectancy after surgical removal of pancreatic cancer.

Our strategy to beat cancer sooner

Our vision is to bring forward the day when all cancers are cured.Our new strategy will give us the foundations we need to tackle the challenges ahead.

More about pancreatic cancer

Find out about symptoms, risk factors and causes of pancreatic cancer and treatment on our Cancer Help pages.

Read the latest statistics for pancreatic cancer.


Share this page